ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $485,000 | +57.0% | 5,216 | +0.5% | 0.01% | +42.9% |
| Q3 2021 | $309,000 | -49.0% | 5,191 | -34.2% | 0.01% | -46.2% |
| Q4 2020 | $606,000 | +2.7% | 7,884 | 0.0% | 0.01% | -7.1% |
| Q3 2020 | $590,000 | +19.0% | 7,884 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $496,000 | +48.5% | 7,884 | -0.8% | 0.01% | +33.3% |
| Q1 2020 | $334,000 | -8.7% | 7,949 | -1.5% | 0.01% | +12.5% |
| Q4 2019 | $366,000 | -2.9% | 8,069 | -1.9% | 0.01% | -11.1% |
| Q3 2019 | $377,000 | -22.4% | 8,226 | -0.8% | 0.01% | -18.2% |
| Q2 2019 | $486,000 | +27.9% | 8,296 | -2.2% | 0.01% | +37.5% |
| Q1 2019 | $380,000 | +15.2% | 8,485 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $330,000 | -22.0% | 8,485 | -7.6% | 0.01% | 0.0% |
| Q3 2018 | $423,000 | – | 9,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |